SCHEMBL6176152

SCHEMBL6176152

Cc1c(CC=O)cccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.60
TSHR P16473 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 4/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
GPR35 Q9HC97 1/20 0.41
HPGD P15428 1/20 0.41
ERN1 O75460 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079985 0.85 TDP1 (0.58) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL29951221 0.82 ALDH1A1 (0.60) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL415792 0.82 ALDH1A1 (0.60) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL14641737 0.82 TDP1 (0.69) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL11002560 0.81 TSHR (0.50) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL16268314 0.79 ALDH1A1 (0.44) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL2148842 0.79 GPR35 (0.60) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL21436326 0.79 ALDH1A1 (0.49) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL2881654 0.79 ALDH1A1 (0.45) TDP1TSHRSMN1; SMN2KMT2AALDH1A1
SCHEMBL715298 0.79 TDP1 (0.64) TDP1TSHRSMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127301-A1 4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS Ikena Oncology, Inc. (US) 2021-06-24 WO disclosed
EP-3102194-A1 BETA-SUBSTITUTED GAMMA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS Quadriga Biosciences, Inc. (US) 2016-12-14 EP disclosed
WO-2015117146-A1 BETA-SUBSTITUTED GAMMA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS QUADRIGA BIOSCIENCES, INC. (US) 2015-08-06 WO disclosed
CN-101585773-B Method for preparing N, N- dipropyl-2-(2-methyl-3-nitro)- ethylammonium chloride JIANGSU KAIYUAN PHARMACEUTICAL CHEMICAL INDUSTRY CO LTD 2013-07-10 CN disclosed
CN-101585773-A Method for preparing N-(2-methyl-3-nitro)-N-propyl-1-propylamin hydrochloride JIANGSU KAIYUAN PHARMACEUTICAL (CN) 2009-11-25 CN disclosed
CN-1286810-C 2-acyl indol derivatives and their use as anti-tumour agents BAKST HEALTH AG (CH) 2006-11-29 CN disclosed
EP-1339683-A4 ESTROGEN RECEPTOR MODULATORS MERCK & CO INC (US) 2005-07-27 EP disclosed
EP-1339683-A2 ESTROGEN RECEPTOR MODULATORS Merck & Co., Inc. (US) 2003-09-03 EP disclosed
CN-1431997-A 2-acylindole derivatives and their use as antitumor agents BAKST HEALTH AG (CH) 2003-07-23 CN disclosed
WO-2002041835-A2 ESTROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2002-05-30 WO disclosed